当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析 - 现金流量表

西藏药业

(600211)

  

流通市值:138.15亿  总市值:138.15亿
流通股本:3.22亿   总股本:3.22亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,030,420,360.83,137,352,266.462,488,285,507.951,631,403,149.1
  收到的税费返还-1,619,757.681,627,627.91,627,627.9
  收到其他与经营活动有关的现金110,568,691.59141,273,779.0187,377,827.9461,907,845.22
  经营活动现金流入小计1,140,989,052.393,280,245,803.152,577,290,963.791,694,938,622.22
  购买商品、接受劳务支付的现金79,889,498.51218,574,565.99202,955,243131,266,052.09
  支付给职工以及为职工支付的现金50,868,310.45108,250,964.780,721,467.4259,814,316.58
  支付的各项税费109,426,338.49379,541,632.58306,210,871.98170,914,154.03
  支付其他与经营活动有关的现金517,353,922.271,569,127,833.961,274,338,468.49732,728,827.9
  经营活动现金流出小计757,538,069.722,275,494,997.231,864,226,050.891,094,723,350.6
  经营活动产生的现金流量净额383,450,982.671,004,750,805.92713,064,912.9600,215,271.62
二、投资活动产生的现金流量:
  收回投资收到的现金1,321,000,0004,370,088,463.93,152,991,516.22,290,217,266.66
  取得投资收益收到的现金5,271,887.9321,965,343.6415,787,481.0711,544,178.19
  处置固定资产、无形资产和其他长期资产收回的现金净额1,363.2344,274.86-215,734.17
  收到的其他与投资活动有关的现金-162,484,572.9161,633,808.81-
  投资活动现金流入小计1,326,273,251.134,554,882,655.33,330,412,806.082,301,977,179.02
  购建固定资产、无形资产和其他长期资产支付的现金3,194,382.2415,957,010.3410,974,808.099,346,117.47
  投资支付的现金1,695,858,801.365,128,000,0003,920,000,0002,690,924,116.43
  投资活动现金流出小计1,699,053,183.65,143,957,010.343,930,974,808.092,700,270,233.9
  投资活动产生的现金流量净额-372,779,932.47-589,074,355.04-600,562,002.01-398,293,054.88
三、筹资活动产生的现金流量:
  取得借款收到的现金310,000,000960,044,596.77816,728,712.81592,245,988.53
  收到其他与筹资活动有关的现金17,121,130.2149,752,596.6-4,014,383.62
  筹资活动现金流入小计327,121,130.211,009,797,193.37816,728,712.81596,260,372.15
  偿还债务支付的现金50,011,046.56482,043,450.52172,032,142.37172,074,396.49
  分配股利、利润或偿付利息支付的现金887,835.71614,742,807.58606,429,827.43321,496,317.15
  其中:子公司支付给少数股东的股利、利润-1,212,2001,212,2001,212,200
  支付其他与筹资活动有关的现金178,286,147.0735,634,096.33--
  筹资活动现金流出小计229,185,029.341,132,420,354.43778,461,969.8493,570,713.64
  筹资活动产生的现金流量净额97,936,100.87-122,623,161.0638,266,743.01102,689,658.51
四、汇率变动对现金及现金等价物的影响-21,090,592.86-22,454,136.39-1,319,965.01-4,034,954.9
五、现金及现金等价物净增加额87,516,558.21270,599,153.43149,449,688.89300,576,920.35
  加:期初现金及现金等价物余额1,576,500,319.481,305,901,166.051,305,901,166.051,305,901,166.05
  期末现金及现金等价物余额1,664,016,877.691,576,500,319.481,455,350,854.941,606,478,086.4
补充资料:
  净利润-916,980,955.72-570,788,875.89
  资产减值准备-4,409,036.31--1,390,321.15
  固定资产和投资性房地产折旧-50,681,742.86-22,593,264.24
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-50,681,742.86-22,593,264.24
  无形资产摊销-28,868,856.29-13,600,918.99
  长期待摊费用摊销-848,553.86-232,454.73
  处置固定资产、无形资产和其他长期资产的损失--108,677.06--152,695.47
  固定资产报废损失-27,349.84--
  公允价值变动损失--1,661,657.85-821,339.67
  财务费用-6,655,899.81--596,985.54
  投资损失--7,872,352.36--4,537,623.79
  递延所得税-18,866,389.41-2,785,433.53
  其中:递延所得税资产减少-18,528,417.75-2,569,513.22
    递延所得税负债增加-337,971.66-215,920.31
  存货的减少--43,304,388.04--15,089,532.53
  经营性应收项目的减少--195,417,961.86--234,758,097.95
  经营性应付项目的增加-225,408,307.81-245,468,066.23
  其他-368,751.18--
  现金的期末余额-1,576,500,319.48-1,606,478,086.4
  减:现金的期初余额-1,305,901,166.05-1,305,901,166.05
  现金及现金等价物的净增加额-270,599,153.43-300,576,920.35
公告日期2026-04-292026-03-132025-10-312025-08-16
审计意见(境内)标准无保留意见
TOP↑